822 related articles for article (PubMed ID: 11424117)
1. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
2. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine.
Young MD; Schneider DL; Zuckerman AJ; Du W; Dickson B; Maddrey WC;
Hepatology; 2001 Aug; 34(2):372-6. PubMed ID: 11481622
[TBL] [Abstract][Full Text] [Related]
3. A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine.
Young MD; Rosenthal MH; Dickson B; Du W; Maddrey WC
Vaccine; 2001 May; 19(25-26):3437-43. PubMed ID: 11348708
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines.
Zuckerman JN; Zuckerman AJ; Symington I; Du W; Williams A; Dickson B; Young MD;
Hepatology; 2001 Oct; 34(4 Pt 1):798-802. PubMed ID: 11584378
[TBL] [Abstract][Full Text] [Related]
5. Recombinant hepatitis B triple antigen vaccine: Hepacare.
Zuckerman JN; Zuckerman AJ
Expert Rev Vaccines; 2002 Aug; 1(2):141-4. PubMed ID: 12901552
[TBL] [Abstract][Full Text] [Related]
6. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults.
Pan HX; Zeng Y; Song XF; Zhang YJ; Xu K; Liang ZL; Zhu FC
Vaccine; 2014 Jun; 32(29):3706-12. PubMed ID: 24681228
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus vaccination for older adults.
Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.
Cassidy WM; Watson B; Ioli VA; Williams K; Bird S; West DJ
Pediatrics; 2001 Apr; 107(4):626-31. PubMed ID: 11335734
[TBL] [Abstract][Full Text] [Related]
9. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
Coates T; Wilson R; Patrick G; André F; Watson V
Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
[TBL] [Abstract][Full Text] [Related]
12. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
Keating GM; Noble S
Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.
Agladioglu S; Beyazova U; Camurdan AD; Sahin F; Atak A
Infection; 2010 Aug; 38(4):269-73. PubMed ID: 20512395
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
16. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
Eyigün CP; Yilmaz S; Gül C; Sengül A; Hacibektasoglu A; Van Thiel DH
J Viral Hepat; 1998 Jul; 5(4):265-9. PubMed ID: 9751013
[TBL] [Abstract][Full Text] [Related]
17. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
19. A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults.
Levie K; Gjorup I; Skinhøj P; Stoffel M
Scand J Infect Dis; 2002; 34(8):610-4. PubMed ID: 12238579
[TBL] [Abstract][Full Text] [Related]
20. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
